Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT), clinical chemistry, chemiluminescent assays, hematology, coagulation, urinalysis and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. We also manufacture analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics.
Getein mAlb Fast Test Kit is used as an aid in the detection of kidney diseases and increased cardiovascular risk in diabetic nephropathy.
Getein CysC Fast Test Kit is used as an aid in the assessment and evaluation of index of glomerular filtration rate, and has important application value in renal function, kidney damage and renal transplantation.
Getein NGAL Fast Test Kit is used as an aid in the early diagnosis of acute kidney injury (AKI), risk classification and treatment monitoring.
Getein β2-MG Fast Test Kit is used as an aid in the detection and evaluation of glomerular filtration rate, renal transplantation and renal function.